Furthermore, a preclinical study of genetically engineered or syngeneic mouse models revealed that the expression of MMP14 in colorectal tumors gave rise to 5-FU resistance through activation of CAFs (32). The gene discussed is MMP14; the disease is colorectal neoplasm.